Episode 114: Understanding hATTR Amyloidosis with Joanna Pearson

This week, Dr. P will be joined by Joanna Pearson, a Patient Education Liaison (PEL) from Alnylam Pharmaceuticals, to discuss a rare, genetic condition that disproportionately affects African Americans. Known as hereditary ATTR amyloidosis, or hATTR amyloidosis, the disease is more common for people of certain ethnicities, including those of African (West African: Ghana, Ivory Coast, Nigeria, and Sierra Leone) and Afro-Caribbean descent.For more information about hATTR amyloidosis, and to request to speak with an Alnylam PEL who can answer questions you may have about hATTR amyloidosis, please visit www.hATTRbridge.com.Content sponsored and provided by Alnylam Pharmaceuticals.ABOUT OUR GUEST: JOANNA PEARSON, RN, BSN, CPRHJoanna Pearson is a Patient Education Liaison at Alnylam Pharmaceuticals. In her role, she is responsible for educating individuals and their families about hereditary transthyretin (hATTR) amyloidosis – a rare, life-threatening condition. Joanna received her Bachelor of Science in Nursing from Ohio University and has worked in patient education at all levels of her career.